Back

Association of Non-HDL cholesterol with cardiovascular risk and subclinical atherosclerosis in patients with rheumatoid arthritis

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Improving cardiovascular risk prediction in rheumatoid arthritis Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Oscar Azael Garza Flores

Dr Jose Eleuterio Gonzalez University Hospital, Monterrey (Mexico)

7 More presentations in this session

Presentation thumbnail
Increased risk of bleeding complications in patients with Rheumatoid arthritis after first acute myocardial infarction
Mr M. Skielta (Ostersund, SE)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes after acute coronary syndrome in patients with rheumatoid arthritis
Doctor J. Sulicka-Grodzicka (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Subclinical coronary artery calcium incidence and progression in rheumatoid arthritis: a 12-year longitudinal cohort study
Mrs P. Estrada (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
CRIP1 as a sex-specific regulator of metabolic and cardiovascular risk
Doctor J. Duque Escobar (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Risk misclassification by cardiovascular risk scores in rheumatoid disease: high prevalence of carotid plaque in patients classified as low risk
Doctor A. Leal Valdez (Monterrey, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Improving cardiovascular risk prediction in rheumatoid arthritis

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardio-rheumatology: what can we learn from rheumatoid arthritis treatment?
4 April 2025
thumbnail
Congress Presentation
Retinal image based artificial intelligence biomarker for cardiovascular risk and cross-sectional association with coronary atherosclerosis
30 August 2026
thumbnail
Congress Session
Atherosclerosis as an inflammatory process (1)
29 August 2026
thumbnail
Congress Presentation
The Apolipoprotein A2/Apolipoprotein C3 ratio predicts future cardiovascular events after percutaneous coronary intervention in patients receiving LDL-cholesterol-lowering therapy
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources